Skip to main content
You are currently using guest access
Log in
  • Home
  • Calendar
  • Home
  • About
    About e-Learning e-Learning Access Editors Editorial Board
  • IBD Curriculum
    Physicians Nurses
  • Course Content
    Educational Audio Podcasts Talking Heads Skills Videos
    e-Courses e-Guide
    IBD Communication Toolbox
  • Webinars
  • Advanced Training
    Ultrasound
    OPTIC Endoscopy
    Endoscopic Scoring Systems (CD) Endoscopic Scoring Systems (UC)
  • e-Library
    Search
    ECCO'23 Congress: Educational Courses Archive 2011 - 2015
  • Partner Societies
    ESGAR ESP IBUS UEG
  • More
ECCO e-Learning
Home Calendar Home About Collapse Expand
About e-Learning e-Learning Access Editors Editorial Board
IBD Curriculum Collapse Expand
Physicians Nurses
Course Content Collapse Expand
Educational Audio Podcasts Talking Heads Skills Videos e-Courses e-Guide IBD Communication Toolbox
Webinars Advanced Training Collapse Expand
Ultrasound OPTIC Endoscopy Endoscopic Scoring Systems (CD) Endoscopic Scoring Systems (UC)
e-Library Collapse Expand
Search ECCO'23 Congress: Educational Courses Archive 2011 - 2015
Partner Societies Collapse Expand
ESGAR ESP IBUS UEG
Expand all Collapse all
  1. ECCO IBD Curriculum
  2. 6. Treatment Options and Individualized Care

6. Treatment Options and Individualized Care

Completion requirements
To understand the treatment options available and be able to discuss them appropriately to provide individualised patient care


Full content only available after log-in


6.1.  Knows the different treatment modalities for IBD taking into account disease extent, activity, previous history and complications

6.2.  Knows the modes of delivery of different drug therapies and their advantages and disadvantages

6.3.  Recognises the importance of patient choice in deciding therapy and in helping to ensure adherence

6.4.  Understands the evidence base behind different therapeutic strategies and when they might be appropriate (conventional step care, optimised step up, top down and treat to target)

6.5.  Appreciates the monitoring requirements for specific therapies

6.6.  Appreciates common side effects and complications of therapy, their frequency and how to manage them

6.7.  Appreciates the importance of on-going disease monitoring to confirm efficacy

6.8.  Understands when surgery is the most appropriate therapeutic option

6.9.  Is up to date with the evidence base from current clinical trial and real world data sets for the use of available therapies

6.10.  Has knowledge of the role of optimising therapy including interpretation of therapeutic drug monitoring for conventional and biological therapies

6.11.  Appreciates the role of stopping medical therapies in IBD and the appropriate timing / patient population in whom drugs can be stopped



Monitoring drug therapy with biomarkers, drug levels and antibody testing

P Irving

13th IBD Intensive Advanced Course Session

Webcast

Topic 6.5Educational update


  • « Previous page
  • 1 Page 1
  • …
  • 29 Page 29
  • 30 Page 30
  • 31 Page 31
  • 32 Page 32
  • 33 Page 33
  • 34 Page 34
  • 35 Page 35
  • 36 Page 36
  • 37 Page 37
  • 38 Page 38
  • …
  • 75 Page 75
  • » Next page
European Crohn's and Colitis Organisation - ECCO
T: +43 (0)1 710 22 42-0
F: +43 (0)1 710 22 42-001
E: ecco@ecco-ibd.eu
  • Home
  • ecco-ibd.eu
  • Contact
  • Imprint
  • Data privacy statement
  • © ECCO 2019 All rights reserved.
Copyright © European Crohn's and Colitis Organisation - ECCO